Kaposi's sarcoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(36 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__


{{CMG}} {{AE}} {{HL}}
{{CMG}} {{AE}} {{F.K}} {{HL}} {{ADS}} {{Hudakarman}}
{{Kaposi's sarcoma}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Kaposi%27s_sarcoma]]


==Overview==
==Overview==
Kaposi's sarcoma must be differentiated from other diseases that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement, such as [[bacillary angiomatosis]], [[AIDS]]-related [[lymphoma]], and [[seborrheic keratosis]].<ref name="radio">Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016</ref><ref name="patho">Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016</ref><ref name="patho2">Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015</ref>
Kaposi's sarcoma must be differentiated from other [[diseases]] that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement, such as [[bacillary angiomatosis]], [[AIDS]]-related [[lymphoma]], and [[seborrheic keratosis]].
==Differentiating Kaposi's Sarcoma from other Diseases==
==Differentiating Kaposi's Sarcoma from other Diseases==
*Kaposi's sarcoma must be differentiated from other diseases that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement, such as:<ref name="radio">Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016</ref><ref name="patho">Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016</ref><ref name="patho2">Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015</ref>
*Kaposi's sarcoma must be differentiated from other [[diseases]] that cause similar [[cutaneous]], [[pulmonary]], and [[gastrointestinal]] involvement.<ref name="radio">Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016</ref><ref name="patho">Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016</ref><ref name="patho2">Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015</ref><small>
:* '''Kaposi's sarcoma cutaneous lesions must be differentiated from:'''
::* [[Bacillary angiomatosis]]
::* [[Arteriovenous malformation]]
::* Acroangiodermatitis
::* Masson's [[hemangioma]]
::* [[Angiosarcoma]]
::* [[Seborrheic keratosis]]
::* Erythematous [[SLE|lupus]]
::* Pigmented purpuric dermatosis
::* [[Pyogenic]] [[granuloma]]
::* Benign lymphangioendothelioma
::* Cavernous [[hemangioma]]
::* Sarcomatoid carcinoma
::* [[Spindle cell]] hemangioendothelioma
 
:* '''Kaposi's sarcoma pulmonary lesions must be differentiated from:'''
::* [[AIDS]]-related [[lymphoma]]
::* [[Atypical pneumonia]]
::* [[Fungus|Fungal]] or [[mycobacteria|mycobacterial]] infection
::* [[Lung cancer]]
 
:* '''Kaposi's sarcoma  gastrointestinal lesions must be differentiated from:'''
::* [[Peptic ulcer disease]]
::* [[Inflammatory bowel disease]] (IBD)
::* [[Gastrointestinal tract cancer]]
 
{|
{|
!
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! colspan="2" |Clinical manifestations
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
! colspan="3" |Lab findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
!Microscopic findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
!Diagnosis
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
!
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Congenital'''
|-
| rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Acquied'''
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
!Lymphadenopathy
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs
!Fever
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
!CBC
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
!LFT
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
!ESR/CRP
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
!Histopathology
| colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]]
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
* HIV
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
 
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
* Chronic lymphocytic leukemia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
 
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
* Cytotoxic chemotherapy
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
 
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
* Organ transplantation
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
|
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Human Immunodeficiency Virus (HIV)|HIV]]
|
*[[Chronic lymphocytic leukemia]]
|
* Cytotoxic [[chemotherapy]]
|
*[[Organ transplant|Organ transplantation]]
|
| style="background:#F5F5F5;" align="center" |
|
| style="background:#F5F5F5;" align="center" |  +
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Any age, usually between 20 -50 years
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | [[Solitary]] or multiple red, purple, flesh-colored, or colorless [[Papule|papules]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="left" |
*[[Anorexia]]
*[[Weight loss]]
*[[Abdominal pain]]
*[[Nausea and vomiting]]
*[[Headache]]
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Lobular vascular proliferations of [[Blood vessel|vessels]] lined by plump [[Endothelium|endothelial cells]]
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="left" |
*[[Mental disorder|Psychiatric disorders]]
*[[Personality|Personality changes]]
*[[Seizure]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acroangiodermatitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
| style="background:#F5F5F5;" align="center" |  +
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | Any age
|
| style="background:#F5F5F5;" align="center" | Nl
|
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" |  +
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="left" |
*[[Headache]]
*[[Neurologic diseases|Neurologic deficits]]
*[[Congestive heart failure|Heart failure]]
*[[Macrocephaly]]
| style="background:#F5F5F5;" align="center" |Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" |NA
| style="background:#F5F5F5;" align="center" |[[Imaging]]
| style="background:#F5F5F5;" align="left" |
*[[Hereditary hemorrhagic telangiectasia]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acroangiodermatitis]]<ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
* Hyperplasia of pre-existing vasculature
|
*[[Hypertension|HTN]]
|
| style="background:#F5F5F5;" align="center" |
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | Any age, more in males
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Purplish-blue to brown [[Papule|papules]] and [[Plaque|plaques]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="left" |
* Paralysed legs
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
*[[Hyperkeratosis]]
* Parakeratosis
*[[Acanthosis nigricans|Acanthosis]]
* Mild spongiosis
| style="background:#F5F5F5;" align="center" | Clinical manifesttations
| style="background:#F5F5F5;" align="left" |
*[[Amputation]]
*[[Hemodialysis|Haemodialysis]] patients with [[Arteriovenous fistula|arteriovenous shunts]]
*[[Hepatitis C]]
*[[Venous insufficiency|Chronic venous insufficiency]]
*[[Arteriovenous malformation|AV malformations]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | Adults, more in males
|
| style="background:#F5F5F5;" align="center" |Enlarging [[bruise]], a blue-black [[Nodule (medicine)|nodule]], or an unhealed [[Ulcer|ulceration]]
|
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Intercellular and intracellular lumina with or without [[Red blood cell|red cells]]
* Intermediate filaments and pinocytotic vesicles in [[cytoplasm]]
*[[Weibel-Palade body|Weibel-Palade bodies]]
| style="background:#F5F5F5;" align="center" |[[Biopsy]]
| style="background:#F5F5F5;" align="center" |NA
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]]
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]])
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" |
|
| style="background:#F5F5F5;" align="center" |Rare
|
| style="background:#F5F5F5;" align="left" |
|
* Normal
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Papillary fronds lined by proliferating [[endothelium]]
| style="background:#F5F5F5;" align="center" |[[Biopsy]]
| style="background:#F5F5F5;" align="left" |
*[[Hemangioma]]
*[[Pyogenic granuloma|Pyogenic granulomas]]
*[[Lymphangioma overview|Lymphangiomas]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pigmented purpuric dermatosis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
* Clonal expansion of a mutated epidermal [[keratinocyte]]
|
| style="background:#F5F5F5;" align="center" | +
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | Any age
|
| style="background:#F5F5F5;" align="left" |
|
* Usually [[asymptomatic]]
| style="background: #F5F5F5; padding: 5px;" |
* Being stuck on the skin surface
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Papillomatous epithelial proliferation containing horn [[Cyst|cysts]]
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="left" |
*[[Dermatosis papulosa nigra]]
* Stucco keratosis
* Melanoacanthoma
* Polypoid lesions
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyogenic]] [[granuloma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | More common in female, typically in the 20 to 30 years
|
| style="background:#F5F5F5;" align="left" |
|
*[[Erythema]] on the [[Mouth|nasolabial folds]]
| style="background: #F5F5F5; padding: 5px;" |
*[[Macule|Macular]] or diffusely erythematous in sun-exposed areas
| style="background: #F5F5F5; padding: 5px;" |
* Discoid rash
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="left" |
*[[Weight loss]]
*[[Headache]]
*[[Arthralgia]]
*[[Myalgia]]
*[[Nausea and vomiting|Nausea]]
*[[Dyspepsia]]
*[[Pleuritic chest pain]]
*[[Dyspnea]]
*[[Hematuria]]
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" |Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
*[[Hyperkeratosis]], epidermal [[atrophy]], vacuolar interface [[dermatitis]]
* Thickening of the [[basement membrane]]
* Superficial, [[Perivascular cell|perivascular]], and perifollicular [[Monocyte|mononuclear cell]] inflammatory infiltrate
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="left" |
*[[Raynaud's phenomenon|Raynaud phenomenon]]
*[[Neuropsychiatry|Neuropsychiatric]] symptoms
*[[Pleural effusion]]
*[[Peptic ulcer|Peptic ulcer disease]]
*[[Pericarditis]]
*[[Myocarditis]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyogenic]] granuloma <ref name="pmid22434943">{{cite journal |vauthors=Kamal R, Dahiya P, Puri A |title=Oral pyogenic granuloma: Various concepts of etiopathogenesis |journal=J Oral Maxillofac Pathol |volume=16 |issue=1 |pages=79–82 |date=January 2012 |pmid=22434943 |pmc=3303528 |doi=10.4103/0973-029X.92978 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Physical trauma|Trauma]]
|
* Hormonal influences
|
*[[Virus|Viruses]]
|
* Cytogenetic clonal deletion abnormalities
|
| style="background:#F5F5F5;" align="center" |  +
|
| style="background:#F5F5F5;" align="center" |  +
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
* Painless red lesion
* Lobular [[capillary hemangioma]]
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" |  +
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Neutrophilic infiltration
*[[Bleeding|Hemorrhage]]
*[[Necrosis]] of the overlying [[Epidermis (skin)|epidermis]]
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="center" |NA
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | +
|
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years
|
| style="background:#F5F5F5;" align="left" |
|
* single, slowly expanding patch, [[plaque]], or [[Nodule (medicine)|nodule]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Thin-walled endothelial-lined spaces that are interspersed between strands of [[collagen]]
| style="background:#F5F5F5;" align="center" |[[Biopsy]]
| style="background:#F5F5F5;" align="center" |NA
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sarcomatoid carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="left" |
| style="background: #F5F5F5; padding: 5px;" |
*[[Idiopathic]]
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | –
|
| style="background:#F5F5F5;" align="center" | Usually in third to fifth decades of life.
|
| style="background:#F5F5F5;" align="left" |
|
* Painless, slowly progressive protrusion or bulging of their globe
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | –
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="left" |
* Engorged vascular channels, which are tightly knit and separated by [[Fiber|fibrous]] septae
| style="background:#F5F5F5;" align="center" | Clinical manidestation
| style="background:#F5F5F5;" align="left" |
*[[Diplopia]]
* Decreased [[color vision]]
*[[Visual field loss|Visual field deficits]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Spindle cell]] hemangioendothelioma
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
|
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hepatosplenomegaly
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lymphadenopathy
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hb
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |LFT
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|}
|}
</small>


==References==
==References==

Latest revision as of 15:18, 10 October 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Haytham Allaham, M.D. [3] Amandeep Singh M.D.[4] Huda A. Karman, M.D.

Overview

Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as bacillary angiomatosis, AIDS-related lymphoma, and seborrheic keratosis.

Differentiating Kaposi's Sarcoma from other Diseases

Diseases Etiology Congenital Acquired Demography Clinical manifestations Lab findings Gold standard diagnosis Associated findings
Symptoms Signs CBC LFT ESR/CRP Histopathology
Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt
Bacillary angiomatosis [4] + Any age, usually between 20 -50 years Solitary or multiple red, purple, flesh-colored, or colorless papules ± ± Nl Nl Nl Nl Nl Nl Clinical manifestation
Arteriovenous malformation [5] + Any age Nl + Nl Nl Nl Nl Nl Nl NA Imaging
Acroangiodermatitis[6] Any age, more in males Purplish-blue to brown papules and plaques Nl
  • Paralysed legs
Nl Nl Nl Nl Nl Clinical manifesttations
Angiosarcoma [7] Adults, more in males Enlarging bruise, a blue-black nodule, or an unhealed ulceration Nl Nl Nl Nl Biopsy NA
Diseases Etiology Congenital Acquired Demography Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt LFT ESR/CRP Histopathology Gold standard diagnosis Associated findings
Masson's hemangioma [8] Rare
  • Normal
Nl Nl Nl Nl Nl Nl Biopsy
Seborrheic keratosis [9] + Any age Nl Nl Nl Nl Nl Nl
  • Papillomatous epithelial proliferation containing horn cysts
Clinical manifestations
Systemic lupus erythematosus (SLE) [10] More common in female, typically in the 20 to 30 years ± ± ± Nl Nl Clinical manifestations
Pyogenic granuloma [11]
  • Trauma
  • Hormonal influences
  • Viruses
  • Cytogenetic clonal deletion abnormalities
+ + Any age, usually in 20-30 years + Nl Nl Nl Nl Nl Nl Clinical manifestation NA
Benign lymphangioendothelioma [12] + Any ages, median age is 50 years Nl Nl Nl Nl Nl Nl
  • Thin-walled endothelial-lined spaces that are interspersed between strands of collagen
Biopsy NA
Cavernous hemangioma [13] Usually in third to fifth decades of life.
  • Painless, slowly progressive protrusion or bulging of their globe
Nl Nl Nl Nl Nl Nl
  • Engorged vascular channels, which are tightly knit and separated by fibrous septae
Clinical manidestation
Diseases Etiology Congenital Acquired Demography Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt LFT ESR/CRP Histopathology Gold standard diagnosis Associated findings

References

  1. Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016
  2. Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016
  3. Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015
  4. Tappero JW, Perkins BA, Wenger JD, Berger TG (July 1995). "Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus". Clin. Microbiol. Rev. 8 (3): 440–50. PMC 174635. PMID 7553576.
  5. Whitehead KJ, Smith MC, Li DY (February 2013). "Arteriovenous malformations and other vascular malformation syndromes". Cold Spring Harb Perspect Med. 3 (2): a006635. doi:10.1101/cshperspect.a006635. PMC 3552339. PMID 23125071.
  6. Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A (2007). "Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports". Acta Dermatovenerol Croat. 15 (3): 152–7. PMID 17868541.
  7. Barttelbort SW, Stahl R, Ariyan S (July 1989). "Cutaneous angiosarcoma of the face and scalp". Plast. Reconstr. Surg. 84 (1): 55–9. PMID 2734404.
  8. Park KK, Won YS, Yang JY, Choi CS, Han KY (July 2012). "Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review". J Korean Neurosurg Soc. 52 (1): 52–4. doi:10.3340/jkns.2012.52.1.52. PMC 3440504. PMID 22993679.
  9. Noiles K, Vender R (2008). "Are all seborrheic keratoses benign? Review of the typical lesion and its variants". J Cutan Med Surg. 12 (5): 203–10. doi:10.2310/7750.2008.07096. PMID 18845088.
  10. Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P (2012). "Cutaneous manifestations of systemic lupus erythematosus". Autoimmune Dis. 2012: 834291. doi:10.1155/2012/834291. PMC 3410306. PMID 22888407.
  11. Kamal R, Dahiya P, Puri A (January 2012). "Oral pyogenic granuloma: Various concepts of etiopathogenesis". J Oral Maxillofac Pathol. 16 (1): 79–82. doi:10.4103/0973-029X.92978. PMC 3303528. PMID 22434943.
  12. Guillou L, Fletcher CD (August 2000). "Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series". Am. J. Surg. Pathol. 24 (8): 1047–57. PMID 10935645.
  13. Goldberg RE, Pheasant TR, Shields JA (December 1979). "Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement". Arch. Ophthalmol. 97 (12): 2321–4. PMID 229814.

Template:WH Template:WS